# Salim S. Hayek

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/salim-s-hayek/

## Facts

| Field | Value |
| --- | --- |
| Citations | 16,622 |
| Field | COVID-19 Clinical Research Studies |
| h-index | 59 |
| i10-index | 159 |
| Last Known Institution | University of Michigan |
| OpenAlex ID | https://openalex.org/A5084303286 |
| ORCID iD | https://orcid.org/0000-0003-0180-349X |
| Works | 365 |

## Researcher papers

- [2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure](https://scholariq.org/papers/2022-aha-acc-hfsa-guideline-for-the-management-of-heart-failure/)
- [Factors Associated With Death in Critically Ill Patients With Coronavirus Disease 2019 in the US](https://scholariq.org/papers/factors-associated-with-death-in-critically-ill-patients-with-coronavirus/)
- [2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure: Executive Summary](https://scholariq.org/papers/2022-aha-acc-hfsa-guideline-for-the-management-of-heart-failure-executive/)
- [Association Between Early Treatment With Tocilizumab and Mortality Among Critically Ill Patients With COVID-19](https://scholariq.org/papers/association-between-early-treatment-with-tocilizumab-and-mortality-among/)
- [Soluble Urokinase Receptor and Chronic Kidney Disease](https://scholariq.org/papers/soluble-urokinase-receptor-and-chronic-kidney-disease/)
- [2022 ACC/AHA/HFSA Guideline for the Management of Heart Failure](https://scholariq.org/papers/2022-acc-aha-hfsa-guideline-for-the-management-of-heart-failure/)
- [AKI Treated with Renal Replacement Therapy in Critically Ill Patients with COVID-19](https://scholariq.org/papers/aki-treated-with-renal-replacement-therapy-in-critically-ill-patients-with-covid/)
- [Bone marrow-derived immature myeloid cells are a main source of circulating suPAR contributing to proteinuric kidney disease](https://scholariq.org/papers/bone-marrow-derived-immature-myeloid-cells-are-a-main-source-of-circulating/)
- [Cardiomuscular Biomarkers in the Diagnosis and Prognostication of Immune Checkpoint Inhibitor Myocarditis](https://scholariq.org/papers/cardiomuscular-biomarkers-in-the-diagnosis-and-prognostication-of-immune/)
- [Thrombosis, Bleeding, and the Observational Effect of Early Therapeutic Anticoagulation on Survival in Critically Ill Patients With COVID-19](https://scholariq.org/papers/thrombosis-bleeding-and-the-observational-effect-of-early-therapeutic/)

## Researcher topics

- [COVID-19 Clinical Research Studies](https://scholariq.org/topics/covid-19-clinical-research-studies/)
- [Protease and Inhibitor Mechanisms](https://scholariq.org/topics/protease-and-inhibitor-mechanisms/)
- [Chemotherapy-induced cardiotoxicity and mitigation](https://scholariq.org/topics/chemotherapy-induced-cardiotoxicity-and-mitigation/)
- [Cardiac Valve Diseases and Treatments](https://scholariq.org/topics/cardiac-valve-diseases-and-treatments/)
- [Long-Term Effects of COVID-19](https://scholariq.org/topics/long-term-effects-of-covid-19/)

## Researcher university

- [University of Michigan](https://scholariq.org/institutions/university-of-michigan/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.